Evidence map›Paper›PMID 32020468›Full record

ReviewCardiovascular drugs and therapy2020

Clinical Cardiovascular Applications of Hyperpolarized Magnetic Resonance.

Andrew J M Lewis, Damian J Tyler, Oliver Rider

Open access · hybridAbstract readReview
In one paragraph

Review in Cardiovascular drugs and therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Scalable Hyperpolarized MRI Enabled by Ace-SABRE of [1-Angewandte Chemie (International ed. in English) · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. HyperpolarizedNMR in biomedicine · 2024
    Article
  7. Review
  8. Review
  9. Article
  10. Volumetric Patch-Based Super-Resolution Reconstruction of HyperpolarizedIEEE access : practical innovations, open solutions · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Temperature Cycling Enables EfficientJournal of the American Chemical Society · 2022
    Article
  15. Review
  16. Review
  17. HyperpolarizedNMR in biomedicine · 2021
    Review
  18. The use of hyperpolarisedBritish journal of cancer · 2021
    Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Andrew J M LewisDepartment of Medicine, University of Oxford Centre for Clinical Magnetic Resonance Research (OCMR), Radcliffe, Oxford, UK. andrew.lewis@cardiov.ox.ac.uk.ORCID 0000-0002-3714-6711
Damian J TylerDepartment of Medicine, University of Oxford Centre for Clinical Magnetic Resonance Research (OCMR), Radcliffe, Oxford, UK.
Oliver RiderDepartment of Medicine, University of Oxford Centre for Clinical Magnetic Resonance Research (OCMR), Radcliffe, Oxford, UK.
John Radcliffe Hospital · GB

Funding

British Heart Foundation FS/14/17/30634British Heart Foundation FS/19/18/34252British Heart Foundation RG/11/9/28921Medical Research Council G0601490
6 · The paper itself

Abstract

Current cardiovascular magnetic resonance imaging techniques provide an exquisite assessment of the structure and function of the heart and great vessels, but their ability to assess the molecular processes that underpin changes in cardiac function in health and disease is limited by inherent insensitivity. Hyperpolarized magnetic resonance is a new technology which overcomes this limitation, generating molecular contrast agents with an improvement in magnetic resonance signal of up to five orders of magnitude. One key molecule, hyperpolarized [1-

Indexed as

Magnetic Resonance ImagingAnimalsCarbon IsotopesCardiovascular DiseasesContrast MediaEnergy MetabolismHumansMyocardiumPredictive Value of TestsPyruvic AcidTissue SurvivalCarbon IsotopesContrast MediaPyruvic AcidCardiovascularHyperpolarizationMagnetic resonance

Identifiers

PMID32020468
PMCPMC7125067
OpenAlexW3004750252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.